Activity Description

This course moves beyond intraocular pressure (IOP) to explore a patient-centric, proactive approach to glaucoma management. Faculty will focus on strategies for early glaucoma detection and treatment, integrating novel diagnostic tools with clinical findings to identify disease progression before vision loss occurs. The session will highlight the role of early procedural intervention, detailing the efficacy and patient selection for modern options such as Selective Laser Trabeculoplasty (SLT) and sustained-release drug delivery systems. A significant portion of the course will be dedicated to MIGS (Minimally Invasive Glaucoma Surgery), covering current techniques, appropriate surgical settings, and patient outcomes. Finally, we will synthesize these elements to discuss the principles of personalized glaucoma care, equipping attendees with a framework to tailor detection and treatment plans to the individual patient's risk profile and quality of life goals.

The Fundingsland Group is accredited by the ACCME to provide continuing medical education for physicians.

Release Date: 02-27-2026
Expiration Date: 02-27-2027

Target Audience

This accredited educational activity is designed for ophthalmologists.

Grant Support Statement

This activity is supported by an unrestricted educational grant from AbbVie.

Faculty  

Christine Funke, MD

• Program Chair
• Barnet Dulaney Perkins Eye Center

Eileen Bowden, MD

• UT Austin Dell Medical School
  

Mary Qiu, MD

• Cleveland Clinic

Manjool Shah, MD

• University of Michigan